CORPORATE NEWS – 14 Feb 2017

corporate-news

Sun Pharma Cons Net Profit at Rs1, 472 Cr Vs Rs 1,546 Cr YoY
Sun Pharma Cons Net Profit at Rs1, 472 Cr Vs Rs 1,546 Cr YoY
Cons Total Income at Rs7, 912.6 Cr
Cons EBITDA at Rs2, 453 Cr
Tax Expense at Rs373 Cr Vs Rs89 Cr YoY.

Godrej Inds reports Q3 consolidated net profit at Rs90 cr
Godrej Industries has announced the following Q3 results for the quarter ended December 31, 2016 (YoY):
Standalone (YoY)
The Company has posted a net loss of Rs42.31 crore Vs net profilt of Rs49.42 crore.
Total Income increased to Rs417.02 crore Vs Rs317.49 crore.

Tata Motors Q3 Cons Profit at Rs112 Cr Vs Rs2, 952.7 Cr
Tata Motors Q3 Cons Profit at Rs112 Cr Vs Rs2, 952.7 Cr (YoY)
Cons Total Income at Rs68, 541 Cr Vs Rs71, 616 Cr (YoY)
JLR EBITDA at £611 m
JLR EBITDA Margin at 9.3%.

Apollo Hosp Q3: Net Profit at Rs72.8 Cr Vs Rs122.3 Cr
Apollo Hosp Q3: Net Profit at Rs72.8 Cr Vs Rs122.3 Cr
Total Income Up 17.9% at Rs1, 680.6 Cr Vs Rs1, 425 Cr (YoY)
Other Income at Rs3.1 Cr Vs Rs66.2 Cr
EBITDA Up 4.5% at Rs194.1 Cr Vs Rs185.7 Cr (YoY)
Hospital Segment EBITDA Margin Stands at 18%
Pharmacy EBITDA Margin at 4.5%.

Vedanta Q3: Cons Net Profit at Rs1, 866 Cr Vs Rs412 Cr
Vedanta Q3: Cons Net Profit at Rs1, 866 Cr Vs Rs412 Cr
Cons Total Income Up 29.6% at Rs20, 393 Cr Vs Rs15, 731 Cr (YoY)
Cons EBITDA Up 76.8% at Rs5, 879 Cr Vs Rs3, 325 Cr
Cons EBITDA Margin at 28.8% Vs 21.1% (YoY).

Capitalstars Financial Research Private Limited is a research house and an investment advisory carrying out operations in the Indian Equities and Commodity market.We also provide 2 days free trial to our client.Join our services and trade with us.

GET MORE DETAILS HERE:-

Commodity Market Tips
Equity Tips
Nifty Future Tips

 

  * INVESTMENT & TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISKS, PAST PERFORMANCE IS NOT A GUARANTEE OF FUTURE PERFORMANCE.
* CAPITALSTARS INVESTMENT ADVISER: SEBI REGISTRATION NUMBER: INA000001647
Advertisements